Deriving Schwann cells from hPSCs enables disease modeling and drug discovery for diabetic peripheral neuropathy Journal Article


Authors: Majd, H.; Amin, S.; Ghazizadeh, Z.; Cesiulis, A.; Arroyo, E.; Lankford, K.; Majd, A.; Farahvashi, S.; Chemel, A. K.; Okoye, M.; Scantlen, M. D.; Tchieu, J.; Calder, E. L.; Le Rouzic, V.; Shibata, B.; Arab, A.; Goodarzi, H.; Pasternak, G.; Kocsis, J. D.; Chen, S.; Studer, L.; Fattahi, F.
Article Title: Deriving Schwann cells from hPSCs enables disease modeling and drug discovery for diabetic peripheral neuropathy
Abstract: Schwann cells (SCs) are the primary glia of the peripheral nervous system. SCs are involved in many debilitating disorders, including diabetic peripheral neuropathy (DPN). Here, we present a strategy for deriving SCs from human pluripotent stem cells (hPSCs) that enables comprehensive studies of SC development, physiology, and disease. hPSC-derived SCs recapitulate the molecular features of primary SCs and are capable of in vitro and in vivo myelination. We established a model of DPN that revealed the selective vulnerability of SCs to high glucose. We performed a high-throughput screen and found that an antidepressant drug, bupropion, counteracts glucotoxicity in SCs. Treatment of hyperglycemic mice with bupropion prevents their sensory dysfunction, SC death, and myelin damage. Further, our retrospective analysis of health records revealed that bupropion treatment is associated with a lower incidence of neuropathy among diabetic patients. These results highlight the power of this approach for identifying therapeutic candidates for DPN. © 2023 The Authors
Keywords: retrospective studies; mouse; animal; animals; mice; drug discovery; drug development; retrospective study; diabetes mellitus; schwann cell; diabetic neuropathy; amfebutamone; schwann cells; sciatic nerve; demyelination; metabolic stress; humans; human; drug repurposing; nerve repair; bupropion; myelination disorders; diabetic neuropathies
Journal Title: Cell Stem Cell
Volume: 30
Issue: 5
ISSN: 1934-5909
Publisher: Cell Press  
Date Published: 2023-05-04
Start Page: 632
End Page: 647.e10
Language: English
DOI: 10.1016/j.stem.2023.04.006
PUBMED: 37146583
PROVIDER: scopus
PMCID: PMC10249419
DOI/URL:
Notes: The MSK Cancer Center Support Grant (P30 CA008748) is acknowledged in the PDF -- Corresponding author is MSK author: Lorenz Studer -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Lorenz Studer
    220 Studer
  2. Gavril W Pasternak
    414 Pasternak
  3. Jason Hung Tchieu
    19 Tchieu
  4. Elizabeth L Calder
    9 Calder